{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:08:44Z","timestamp":1761718124316},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.12.010","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T09:08:18Z","timestamp":1261472898000},"page":"1668-1672","source":"Crossref","is-referenced-by-count":19,"title":["Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Danica K.","family":"Hickey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Aldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth W.","family":"Beagley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2009.12.010_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0378(00)00069-3","article-title":"Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development","volume":"48","author":"Beagley","year":"2000","journal-title":"J Reprod Immunol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.12.010_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/oxfordjournals.bmb.a071806","article-title":"Chlamydial salpingitis","volume":"39","author":"Westrom","year":"1983","journal-title":"Br Med Bull"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.12.010_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.181.4.1493","article-title":"Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients\u2019 mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis","volume":"181","author":"Ho","year":"1995","journal-title":"J Exp Med"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2009.12.010_bib4","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/522006","article-title":"Prevalent Herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections","volume":"196","author":"Kaul","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.12.010_bib5","series-title":"Proceedings of the Chlamydia vaccine development colloquium; 2004","first-page":"15","article-title":"Rationale for a vaccine","author":"Stamm","year":"2004"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.12.010_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI11348","article-title":"Oral tolerance, an active immunologic process mediated by multiple mechanisms","volume":"106","author":"Weiner","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.010_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-5699(98)01397-8","article-title":"Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic","volume":"20","author":"Williams","year":"1999","journal-title":"Immunol Today"},{"issue":"9","key":"10.1016\/j.vaccine.2009.12.010_bib8","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.010_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.12.010_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7589\/0090-3558-44.2.247","article-title":"Efficacy of oral and parenteral routes of Mycobacterium bovis Bacille Calmette-Guerin vaccination against experimental bovine tuberculosis in white-tailed deer (Odocoileus virginianus): a feasibility study","volume":"44","author":"Nol","year":"2008","journal-title":"J Wildl Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.010_bib11","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/IAI.00052-08","article-title":"Oral vaccination of guinea pigs with Mycobacterium bovis Bacille Calmette-Guerin (BCG) vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis","volume":"76","author":"Clark","year":"2008","journal-title":"Infect Immun"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2009.12.010_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.010_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/IAI.72.2.1019-1028.2004","article-title":"Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection","volume":"72","author":"Berry","year":"2004","journal-title":"Infect Immun"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2009.12.010_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2007.12.048","article-title":"In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB","volume":"26","author":"Barker","year":"2008","journal-title":"Vaccine"},{"issue":"May\u2013June (4)","key":"10.1016\/j.vaccine.2009.12.010_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/icb.2009.3","article-title":"Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice","volume":"87","author":"Carey","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.010_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0264-410X(96)00159-4","article-title":"Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles","volume":"15","author":"Challacombe","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.12.010_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00207710","article-title":"Influenza specific antibodies in the female genital tract of mice after oral administration of live influenza vaccine","volume":"240","author":"Briese","year":"1987","journal-title":"Arch Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.010_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1095\/biolreprod56.1.33","article-title":"Antibody responses and infertility in mice following oral immunization with attenuated Salmonella typhimurium expressing recombinant murine ZP3 [published erratum appears in Biol Reprod 1997 Apr;56(4):1069]","volume":"56","author":"Zhang","year":"1997","journal-title":"Biol Reprod"},{"issue":"10","key":"10.1016\/j.vaccine.2009.12.010_bib19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm1096-1116","article-title":"Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection","volume":"2","author":"Whittum-Hudson","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.010_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007435-197804000-00011","article-title":"The potential for vaccine against infection of the genital tract with Chlamydia trachomatis","volume":"5","author":"Grayston","year":"1978","journal-title":"Sex Transm Dis"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2009.12.010_bib21","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.vaccine.2005.11.017","article-title":"Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis","volume":"24","author":"Aldwell","year":"2006","journal-title":"Vaccine"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.12.010_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MCO.0b013e3280177687","article-title":"Lipases and lipolysis in the human digestive tract: where do we stand?","volume":"10","author":"Armand","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.010_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat Immunol"},{"issue":"February","key":"10.1016\/j.vaccine.2009.12.010_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-065X.2003.00001.x","article-title":"The roles of membrane microdomains (rafts) in T cell activation","volume":"191","author":"Horejsi","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.12.010_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.immunol.21.120601.141021","article-title":"Location is everything: lipid rafts and immune cell signaling","volume":"21","author":"Dykstra","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.12.010_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/77842","article-title":"Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation","volume":"1","author":"Anderson","year":"2000","journal-title":"Nat Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.12.010_bib27","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1073\/pnas.74.11.4895","article-title":"Response of endocytosis to altered fatty acyl composition of macrophage phospholipids","volume":"74","author":"Mahoney","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.12.010_bib28","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.174.9.5390","article-title":"Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4","volume":"174","author":"Weatherill","year":"2005","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.12.010_bib29","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1194\/jlr.M600329-JLR200","article-title":"Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression","volume":"47","author":"Schweitzer","year":"2006","journal-title":"J Lipid Res"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.12.010_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1042\/bst0171042","article-title":"Fatty acid inhibition of concanavalin A-stimulated lymphocyte proliferation","volume":"17","author":"Calder","year":"1989","journal-title":"Biochem Soc Trans"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.12.010_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1042\/bst0180904","article-title":"Fatty acid inhibition of lipopolysaccharide-stimulated B lymphocyte proliferation","volume":"18","author":"Calder","year":"1990","journal-title":"Biochem Soc Trans"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:58:46Z","timestamp":1558720726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09019148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09019148"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}